Becton Dickinson & Co (BDX)
226.95
+0.51
(+0.23%)
USD |
NYSE |
Dec 24, 16:00
Becton Dickinson Research and Development Expense (Quarterly): 302.00M for Sept. 30, 2024
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
Boston Scientific Corp | 407.00M |
Merit Medical Systems Inc | 20.53M |
Abbott Laboratories | 713.00M |
Baxter International Inc | 129.00M |
ResMed Inc | 79.52M |